secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acurx Pharmaceuticals, Inc. (ACXP)
CIK:        0001736243
Form:       8-K
Filed at:   2025-05-08T23:59:59+00:00
Accession:  0001104659-25-046167
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acurx Pharmaceuticals secures up to $12M equity line from Lincoln Park Capital
------------------------------------------------------------------------------

- Lincoln Park committed to purchase up to $12M in common stock over 24 months.
- Regular purchases up to 60k shares/day (90k if stock ≥$2, 120k if ≥$3).
- Purchase price set at 97% of lowest of day's low or avg of three lowest closes in prior 10 days.
- Company issued 899,258 commitment shares to Lincoln Park as consideration.
- Proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/0001104659-25-046167-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736243/000110465925046167/tm2514277d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-046167

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer